Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Viatris
Pharma
China deal growth, Daiichi CMO, Astellas-Vir—Fierce Pharma Asia
The value of Chinese licensing deals has surged. Daiichi hired John Tsai as its R&D head. Astellas and Vir partnered on a cancer bispecific. And more.
Angus Liu
Feb 27, 2026 9:50am
Viatris to cut 10% of workforce in 3-year overhaul
Feb 26, 2026 9:25am
Novartis settles lawsuit with estate of Henrietta Lacks
Feb 24, 2026 10:20am
JPM26, Day 2: Novo CEO talks 'mastering' cash pay sales in '26
Jan 13, 2026 7:29pm
Pfizer-Fosun, Zealand, China's new formulary—Fierce Pharma Asia
Dec 12, 2025 8:15am
Biocon buys out Viatris and others from biosimilar subsidiary
Dec 9, 2025 1:56pm
